10 Ways To Improve Your CDMO Partnerships

By Joyce Lifland, PhD, Senior Sales Executive, Apprentice

In 2021, the pharmaceutical Contract Development and Manufacturing (CDMO) market size was valued at $186.62 billion, and is expected to grow to a whopping $289.64 by 2027 — representing a compound annual growth rate of 7.29%.

Although the market is poised for rapid growth, various challenges related to the pandemic (including a massive uptick in demand) have resulted in long CDMO lead times, supply shortages, and visibility issues. 

In this article, we’ll explore what CDMOs are, why they’re necessary, and ten ways pharma companies can improve their partnerships — regardless of market conditions.